Division of Neurosurgery, Department of Surgery, College of Medicine and Hospital, National Taiwan University, Taipei 10051, Taiwan.
Institute of Toxicology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan.
Nutrients. 2021 Nov 1;13(11):3921. doi: 10.3390/nu13113921.
Nootkatone is one of the major active ingredients of , which has been used as both food and medicinal plants for the treatment of diarrhea, ulceration, and enuresis. In this study, we aimed to investigate whether nootkatone treatment ameliorated the progression of chronic kidney diseases (CKD) and clarified its underlying mechanisms in an obstructive nephropathy (unilateral ureteral obstructive; UUO) mouse model. Our results revealed that nootkatone treatment preventively decreased the pathological changes and significantly mitigated the collagen deposition as well as the protein expression of fibrotic markers. Nootkatone could also alleviate oxidative stress-induced injury, inflammatory cell infiltration, and renal cell apoptotic death in the kidneys of UUO mice. These results demonstrated for the first time that nootkatone protected against the progression of CKD in a UUO mouse model. It may serve as a potential therapeutic candidate for CKD intervention.
诺卡酮是 的主要活性成分之一,被用作治疗腹泻、溃疡和遗尿的食物和药用植物。在这项研究中,我们旨在探讨诺卡酮治疗是否能改善慢性肾脏病(CKD)的进展,并在梗阻性肾病(单侧输尿管梗阻;UUO)小鼠模型中阐明其潜在机制。我们的结果表明,诺卡酮治疗可预防地减少病理变化,并显著减轻胶原沉积以及纤维化标志物的蛋白表达。诺卡酮还可以减轻 UUO 小鼠肾脏中氧化应激诱导的损伤、炎性细胞浸润和肾细胞凋亡死亡。这些结果首次表明,诺卡酮可防止 UUO 小鼠模型中 CKD 的进展。它可能成为 CKD 干预的潜在治疗候选药物。